1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALPHA COGNITION INC
Alpha Cognition Inc
XNAS: ACOG
5.95 -0.02 (-0.34%)
18,516
XNAS Volume

XNAS 01 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert



Insider Trading disclosures for Alpha Cognition Inc

The latest disclosure was made by Rajeev Bakshi in Alpha Cognition Inc where a trade of 7,241 Common Shares done was reported to US exchanges on Jan. 14, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Rajeev Bakshi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2026 7,241 12,283 - 0 Common Shares
Rajeev Bakshi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2026 8,437 8,437 - - Common Share Options
Phillip Mertz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2026 8,437 8,437 - - Common Share Options
Phillip Mertz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2026 7,241 29,703 - 0 Common Shares
Len Mertz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2026 7,241 145,736 - 0 Common Shares
Len Mertz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2026 8,437 8,437 - - Common Share Options
Kenneth A. Cawkell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2026 8,437 8,437 - - Common Share Options
Kenneth A. Cawkell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2026 7,241 107,740 - 0 Common Shares
Michael McFadden Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2026 190,549 190,549 - 0 Common Shares
Henry Du VP Finance and Accounting Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2026 15,982 15,982 - - Common Share Options
Henry Du VP Finance and Accounting Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2026 20,579 20,579 - 0 Common Shares
Lauren D'Angelo Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2026 106,545 106,545 - - Common Share Options
Lauren D'Angelo Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2026 137,195 137,195 - 0 Common Shares
Michael McFadden Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2026 177,576 177,576 - - Common Share Options
Michael McFadden Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2026 76,220 76,220 - - Performance Share Units
Phillip Mertz Director Sale of securities on an exchange or to another person at price $ 9.00 per share. 18 Aug 2025 27,778 22,462 - 9 250,002 Common Shares
Len Mertz Director Purchase of securities on an exchange or from another person at price $ 9.00 per share. 18 Aug 2025 27,778 121,503 - 9 250,002 Common Shares
John Havens Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2025 38,762 38,762 - - Common Share Options
Lauren D'Angelo Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2025 298,168 298,168 - - Common Share Options
Rajeev Bakshi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2025 38,762 38,762 - - Common Share Options
Phillip Mertz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2025 38,762 38,762 - - Common Share Options
Len Mertz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2025 55,659 55,659 - - Common Share Options
Michael McFadden Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2025 496,947 496,947 - - Common Share Options
Kenneth A. Cawkell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2025 38,762 38,762 - - Common Share Options
Michael McFadden Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 5.75 per share. 13 Nov 2024 2,608 14,142 - 5.8 14,996 Common Shares
John Havens Director 13 Nov 2024 4,347 273,272 - 5.7 24,995 Common Shares
Len Mertz Director Purchase of securities on an exchange or from another person at price $ 5.75 per share. 13 Nov 2024 8,695 93,725 - 5.7 49,996 Common Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures